A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease
Clinical trial NCT04002830 · COMPLETED
Trial details
- NCT number
- NCT04002830
- Sponsor
- Ari Zimran
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-20
- Primary completion
- 2023-07-30
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.